Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
Full metadata record
|dc.identifier.citation||Xenobiotica, 1999; 29(10):973-986||en|
|dc.description.abstract||The aims were to examine the kinetics of the oxidative metabolism of flunitrazepam in vitro when flunitrazepam was dissolved in dimethylformamide and acetonitrile, and to determine which cytochrome P450 isoform(s) are involved. The kinetics of the formations of 3'-hydroxyflunitrazepam and desmethyl-flunitrazepam were non-linear and best estimated using the Hill equation. Inhibition of their formation was studied using specific chemical inhibitors, expressed enzyme systems and specific antibodies. Ks, Vmax, Clmax and n (slope factor) for the formation of 3'-hydroxyflunitrazepam and desmethylflunitrazepam had ranges of 165-338 and 179 391 microM, 22-81 and 3-10 nmol x mg protein(-1) x h(-1), 6-17 and 0.9-1.9 microl x mg protein(-1) x h(-1), and 2.3-3.6 and 1.6-2.6 respectively when dimethylformamide was the organic solvent. When acetonitrile was the solvent, Ks, Vmax, Clmax and n (slope factor) for the formation of 3'-hydroxyflunitrazepam and desmethylflunitrazepam had ranges of 173-231 and 74-597 microM, 35-198 and 2.7-48 nmol.mg protein(-1) x h(-1), 1347 and 0.7-6.3 microl.mg protein(-1) x h(-1), and 1.5-3.6 and 1.1-2.7 respectively. CYP2C19, CYP3A4 and CYP1A2 mediated the formation of both 3'-hydroxyflunitrazepam and desmethylflunitrazepam. Investigators need carefully to consider the choice of organic solvent to avoid false CYP identification.||en|
|dc.publisher||TAYLOR & FRANCIS LTD||en|
|dc.subject||Microsomes, Liver; Humans; Dimethylformamide; Acetonitriles; Flunitrazepam; Benzoflavones; Cytochrome P-450 Enzyme System; Aryl Hydrocarbon Hydroxylases; Mixed Function Oxygenases; Antibodies, Monoclonal; Solvents; Enzyme Activation; Oxidation-Reduction; Kinetics; Genotype; Adult; Aged; Middle Aged; Female; Male; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP2C19||en|
|dc.title||Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4||en|
|dc.identifier.orcid||Coller, J. [0000-0002-8273-5048]||en|
|dc.identifier.orcid||Somogyi, A. [0000-0003-4779-0380]||en|
|Appears in Collections:||Pharmacology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.